David P. Southwell, Director at PTC THERAPEUTICS, INC. (PTCT), sold 27,000 shares at $51.50 ($1.4M) on 2020-10-16, disclosed to the SEC on 2020-10-20.
Open-market sale of $1.4M PTCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.50 | 14,300 | $736K | 52.9% |
| 2 | $51.52 | 11,500 | $592K | 42.6% |
| 3 | $52.18 | 500 | $26K | 1.9% |
| 4 | $52.18 | 700 | $37K | 2.6% |
| Total | $51.54 avg | 27,000 | $1.4M | 100% |
| Filing → |
| PTCT | SELL | 2023-04-19 | $1.2M | — | Filing → |
| PTCT | SELL | 2023-04-04 | $257K | — | Filing → |
| PTCT | SELL | 2023-03-29 | $897K | — | Filing → |